ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 257 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $521 | -22.8% | 14,623 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $675 | -4.5% | 14,623 | -17.0% | 0.00% | 0.0% |
| Q1 2023 | $707 | +24.9% | 17,623 | +44.2% | 0.00% | 0.0% |
| Q4 2022 | $566 | -99.9% | 12,223 | +16.2% | 0.00% | +33.3% |
| Q3 2022 | $436,000 | -30.6% | 10,523 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $628,000 | -17.8% | 10,523 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $764,000 | -13.7% | 10,523 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $885,000 | -6.7% | 10,523 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $949,000 | -5.4% | 10,523 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $1,003,000 | -20.8% | 10,523 | -5.4% | 0.01% | -28.6% |
| Q1 2021 | $1,266,000 | -8.7% | 11,123 | +11.0% | 0.01% | -12.5% |
| Q4 2020 | $1,387,000 | +68.3% | 10,023 | 0.0% | 0.01% | +33.3% |
| Q3 2020 | $824,000 | -38.9% | 10,023 | -41.9% | 0.01% | 0.0% |
| Q2 2020 | $1,348,000 | +137.3% | 17,246 | +115.6% | 0.01% | -64.7% |
| Q3 2016 | $568,000 | +45.3% | 8,000 | 0.0% | 0.02% | +6.2% |
| Q2 2016 | $391,000 | -22.7% | 8,000 | 0.0% | 0.02% | -27.3% |
| Q1 2016 | $506,000 | -71.8% | 8,000 | -50.0% | 0.02% | -37.1% |
| Q4 2015 | $1,795,000 | – | 16,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |